Carbohydrate Approach to Difluorinated D-Proline Analogues
SynOpen · 19.11.2026
DOI: 10.1055/a-3009-4145 ↗Kurz gefasst
Fachartikel in der Zeitschrift SynOpen, erschienen am 19.11.2026. Verfasst von Mathilde Grosset-Magagne und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Université Laval, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Fluorinated D-proline derivatives are valuable yet underexplored building blocks for peptide engineering, chemical biology, and medicinal chemistry. Herein, we report a carbohydrate-based approach to the stereoselective synthesis of two difluorinated D-proline analogues, namely (2S,3S,4S)-and (2S,3S,4R)-N-tosyl-3,4-difluoroproline methyl esters. The synthetic strategy exploits levoglucosan-derived difluorinated carbohydrates as stereochemically defined precursors to fluorinated pyrrolidine iminosugars. These intermediates are subsequently transformed into difluorinated D-proline derivatives through oxidative cleavage of the carbohydrate backbone, followed by oxidation and esterification. This approach provides access to original difluorinated D-proline analogues as well as fluorinated pyrrolidine iminosugar intermediates, further expanding the synthetic utility of levoglucosan-derived fluorinated carbohydrates.
Förderung
- Université Laval
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Grosset-Magagne, M., Sorne, I. L., Guérin, M., & Giguère, D. (2026). Carbohydrate Approach to Difluorinated D-Proline Analogues. SynOpen. https://doi.org/10.1055/a-3009-4145
Vancouver
Grosset-Magagne M, Sorne IL, Guérin M, Giguère D. Carbohydrate Approach to Difluorinated D-Proline Analogues. SynOpen. 2026. doi:10.1055/a-3009-4145
BibTeX
@article{GrossetMagagne2026,
author = {Grosset-Magagne, Mathilde and Sorne, Inès le and Guérin, Mathilde and Giguère, Denis},
title = {Carbohydrate Approach to Difluorinated D-Proline Analogues},
journal = {SynOpen},
year = {2026},
doi = {10.1055/a-3009-4145}
}
EUVIMED